In this exciting role you will be responsible for working directly with project/program teams in research, exploratory development and full development to design. You will also interpret the non-clinical safety aspects of drug development for assigned projects. Your primary emphasis will be on drug candidates for respiratory and gastrointestinal indications, specifically defining potential adverse effects and strategies for discovery teams and developing and executing toxicology plans for first in human and proof-of-concept clinical trials. 

You will compile, gain endorsement of and update line function-specific development plans to support the candidate’s Safety Profiling Plan (SPP) and Development Plan (DP). Monitoring timelines, objectives and budgets to align with development team goals, will also be part of your remit, as will managing the preparation and presentation of documentation relating to nonclinical safety for specific projects and aiding in safety assessments for leachables and extractables relating to respiratory drug delivery systems. 

Able to clearly identify and communicate potential project hurdles, you will suggest solutions and establishes priorities and contingency plans in collaboration with Safety Profiling and Assessment (SP&A) line function management and project team participants. With a PhD in pharmacology, toxicology or a related biological science ; DVM with appropriate training and experience. PharmD or equivalent with a strong biological background or equivalent work experience you will be an experienced preclinical representative on multidisciplinary drug development teams, including pulmonary drug development.

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented, performance-driven people. All of which makes us one of the most rewarding employers in our field.